Scholars@Duke
bioRxiv

Directed evolution of angiotensin-converting enzyme 2 (ACE2) peptidase activity profiles for therapeutic applications

Publication ,  Preprint
Heinzelman, P; Romero, P
2022
Published version (DOI)

Duke Scholars

Philip A Romero
Author Philip A Romero Biomedical Engineering
Altmetric Attention Stats
Dimensions Citation Stats

DOI

10.1101/2022.01.03.474817

Publication Date

2022
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Heinzelman, P., & Romero, P. (2022). Directed evolution of angiotensin-converting enzyme 2 (ACE2) peptidase activity profiles for therapeutic applications. bioRxiv. https://doi.org/10.1101/2022.01.03.474817
Heinzelman, Pete, and Philip Romero. “Directed evolution of angiotensin-converting enzyme 2 (ACE2) peptidase activity profiles for therapeutic applications.” BioRxiv, 2022. https://doi.org/10.1101/2022.01.03.474817.
Heinzelman, Pete, and Philip Romero. “Directed evolution of angiotensin-converting enzyme 2 (ACE2) peptidase activity profiles for therapeutic applications.” BioRxiv, 2022. Epmc, doi:10.1101/2022.01.03.474817.

DOI

10.1101/2022.01.03.474817

Publication Date

2022